192 related articles for article (PubMed ID: 21574948)
21. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
Huq I; Tamilarasu N; Rana TM
Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
[TBL] [Abstract][Full Text] [Related]
22. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
[TBL] [Abstract][Full Text] [Related]
23. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.
Chavali SS; Mali SM; Jenkins JL; Fasan R; Wedekind JE
J Biol Chem; 2020 Dec; 295(49):16470-16486. PubMed ID: 33051202
[TBL] [Abstract][Full Text] [Related]
24. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
Xie B; Wainberg MA; Frankel AD
J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
26. Design-Based Peptidomimetic Ligand Discovery to Target HIV TAR RNA Using Comparative Analysis of Different Docking Methods.
Fu J; Xia A; Dai Y; Qi X
Curr HIV Res; 2016; 14(6):476-483. PubMed ID: 27450546
[TBL] [Abstract][Full Text] [Related]
27. Iron(II) supramolecular helicates interfere with the HIV-1 Tat-TAR RNA interaction critical for viral replication.
Malina J; Hannon MJ; Brabec V
Sci Rep; 2016 Jul; 6():29674. PubMed ID: 27405089
[TBL] [Abstract][Full Text] [Related]
28. How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape.
Bardaro MF; Shajani Z; Patora-Komisarska K; Robinson JA; Varani G
Nucleic Acids Res; 2009 Apr; 37(5):1529-40. PubMed ID: 19139066
[TBL] [Abstract][Full Text] [Related]
29. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
Richter S; Cao H; Rana TM
Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
[TBL] [Abstract][Full Text] [Related]
30. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
31. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
Churcher MJ; Lowe AD; Gait MJ; Karn J
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
[TBL] [Abstract][Full Text] [Related]
32. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
Long KS; Crothers DM
Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
[TBL] [Abstract][Full Text] [Related]
33. RNA conformation in the Tat-TAR complex determined by site-specific photo-cross-linking.
Wang Z; Rana TM
Biochemistry; 1996 May; 35(20):6491-9. PubMed ID: 8639596
[TBL] [Abstract][Full Text] [Related]
34. In vitro selection of HIV-1 TAR variants by the Tat protein.
Marozzi A; Meneveri R; Giacca M; Gutierrez MI; Siccardi AG; Ginelli E
J Biotechnol; 1998 Apr; 61(2):117-28. PubMed ID: 9654745
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
36. Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein.
Davidson A; Patora-Komisarska K; Robinson JA; Varani G
Nucleic Acids Res; 2011 Jan; 39(1):248-56. PubMed ID: 20724442
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 Tat protein is able to efficiently transactivate the HIV-2 LTR through a TAR RNA element lacking both dinucleotide bulge binding sites.
Rhim H; Rice AP
Virology; 1995 Jan; 206(1):673-8. PubMed ID: 7831824
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
Rana TM; Jeang KT
Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
[TBL] [Abstract][Full Text] [Related]
40. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
Bradrick TD; Marino JP
RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
